SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Brevet et autres moyens de protection des inventions pharmaceutiques
3 references·0 citing·8 second hop
Brevet et autres moyens de protection des inventions pharmaceutiques (2004)Brevet et autres moyens de protection des…New drug approvals for 2002 (2003)New drug approvals for 2002Intellectual property and chirality of drugs (1999)Intellectual property and chi…Returns to R&D on new drug introductions in the 1980s (1994)Returns to R&D on new drug in…Cost of innovation in the pharmaceutical industry (1991)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Strategic determinants of decisions not to settle patent litigation (2002)The price of innovation: new estimates of drug development costs (2003)The Pharmaceutical Industry (2013)On the Misuse of Accounting Rates of Return to Infer Monopoly Profits (2016)A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States (2008)The strategy of enantiomer patents of drugs (2010)
this work references cited by second hop

References

  • 1994Returns to R&D on new drug introductions in the 1980s197 cited
  • 1999Intellectual property and chirality of drugs131 cited
  • 2003New drug approvals for 200253 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work